×

Login

  • Lost Password

SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

CREATE AN ACCOUNT FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

CREATE ACCOUNT

ALREADY HAVE AN ACCOUNT?

Karma1

  • The most followed
  • New technologies
  • What is Karma1
    • How does it work?
    • What are the karmas?
  • Tell us your opinion
  • SIGN UP
  • LOGIN
Advanced Search
  • Aerospace
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Energy
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Environment
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Hardware
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Health & life sciences
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Manufacturing technologies
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Materials
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Robotics
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Software
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Transport
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL

Body Vision Medical Receives FDA Clearance for LungVision 2.0 System, a Part of LungVision Platform, Demonstrated at ATS 2019

by Body Vision Medical / Saturday, 18 May 2019 / Published in Hardware, Health & life sciences

Physicians explore how the cutting-edge technology helps them visualize, access and biopsy small lung lesions in real time with high accuracy, while in the standard bronchoscopy suite.

 

Body Vision Medical, a medical device company specializing in augmented real-time imaging, artificial intelligence and intra-body navigation, announced today that it has received clearance from the U.S. Food and Drug Administration to market their LungVision™ 2.0 System.  The new release of LungVision System features real-time tool-in-lesion confirmation combined with seamless integration of LungVision Tool, a disposable lung navigation catheter with superb maneuverability. LungVision Tool ™  guided by LungVision™  2.0 System is used through the standard bronchoscopes to allow access of any endotherapy accessories to small pulmonary nodules.

LungVision™ platform has demonstrated outstanding results through multicenter clinical trials in the U.S. of over 400 clinical procedures. Utilizing machine learning and a sophisticated augmented reality approach for accurate real-time navigation, LungVision™  allows physicians to plan, visualize, and track endobronchial tools inside the radiolucent lesions in real time. LungVision™  instantly fuses intraoperative imaging with pre-operative CT.  “The second release of LungVision™  allows real-time tool-in-lesion confirmation through C-Arm Based Tomography (CABT) to provide an accurate access to pulmonary nodules. LungVision™  2.0 reveals fluoroscopically “blind” lesions during biopsy sampling by means of any conventional C-Arm, which is widely available in a standard bronchoscopy suite. Real-time tool-in-lesion confirmation is required for successful diagnoses of pulmonary nodules and will ultimately be imperative in the future application of minimally invasive treatment.” says Dorian Averbuch, the CEO and Founder of Body Vision Medical.

 

Body Vision Medical will exhibit its LungVision 2.0 platform at the ATS Annual Meeting 2019, held in Dallas through May 19-21. In addition, Body Vision Medical features two presentations of LungVision studies:

Krish Bhadra, MD, CHI Memorial Hospital, will present the strengths of artificial intelligence in navigational bronchoscopy. The AI-based technology is tracking complex anatomy and operational tools, making the guidance of diagnostic biopsy reliable and meaningful during procedure. This in turn translates into better control of procedure and high diagnostic results.
A72, Sunday, May 19th, 11:15AM – 1:00 PM, Session name: “Advances in Interventional Pulmonary”

Daniel Nader, MD, Cancer Treatment Centers of America, will present the contribution of the LungVision Platform in fiducial marker placement to increase efficiency of SBRT radio surgery.

A110, Sunday, May 19th, 2:15PM – 4:15PM, Session name: “Novel Imaging for Lung Cancer: A Picture is Worth a Thousand Words”

.

Contact email: info@bodyvisionmedical.com

SOURCE Body Vision Medical

 

Tagged under: Artificial intelligence, augmented reality, cancer, computer vision, machine learning, Machine vision, oncology

Comments

K2

Follow this technology

You are not registered.Sign in to follow the development of this technology.

Developed technologies

Meet other technologies investigated by Body Vision Medical

Related Technologies

Varian Launches Game-Changing Treatment Platform to Answer the Global Cancer Challenge.
Burns & McDonnell and Manitoba Hydro International Partner to Implement VisualSpection™ Augmented Reality Software for Wearable Devices
FABU’s High-Performance, Coarse-grained Deep Learning Accelerator (DLA) Poised to Improve Accuracy of Computer Vision
The first and only seed phenotype analysis system for rapid, reliable andcost-efficient breeding
Cantargia: Phase I safety evaluation part of CANFOUR trial of antibody CAN04 completed and phase IIa part being initiated
  • Contacting us
  • Advertise With Us
  • Legal notice and privacy policy
  • Terms of Service
Karma1

© 2017 KARMA1. All Rights Reserved.
Programador Wordpress

TOP